FDA announces nationwide recall of blood pressure drug due to dissolution failure
Just the facts

FDA announces nationwide recall of blood pressure drug due to dissolution failure

Summary

More than 11,000 bottles of the diuretic chlorthalidone are being recalled after testing showed they did not meet dissolution specifications.

An Indian manufacturer is voluntarily recalling over 11,000 bottles of chlorthalidone, a medication used to treat high blood pressure, after the products failed dissolution testing, the Food and Drug Administration said. The recall covers 100-tablet and 1,000-tablet bottles sold across the United States. Dissolution testing measures how quickly a drug dissolves and releases its active ingredient in liquid, a process used to assess formulation quality and batch consistency, according to pharmaceutical technology firm Pion. The medication was produced by Inventia Healthcare Limited in India and distributed in the U.S. by Rising Pharma Holdings, Inc., based in East Brunswick, New Jersey. The FDA advises patients and healthcare providers to check whether they have the affected product and to follow recall instructions.

Keep reading — for free

Create a free account to follow the news. No card required.